Page last updated: 2024-11-12

dihydroagarofuran

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

dihydroagarofuran: alpha & beta dihydroagarofuran are stereoisomers; RN given refers to alpha-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dihydroagarofuran : A eudesmane sesquiterpenoid that is octahydro-2H-3,9a-methano-1-benzoxepine substituted by methyl groups at positions 2, 2, 5a and 9 (the 3R,5aS,9R,9aS stereoisomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID21593552
CHEBI ID71547
SCHEMBL ID2400604
MeSH IDM0213896

Synonyms (13)

Synonym
dihydroagarofuran
trans-dihydroagarofuran
2h-3,9a-methano-1-benzoxepin, octahydro-2,2,5a,9-tetramethyl-
octahydro-2,2,5a,9-tetramethyl-2h-3,9a-methano-1-benzoxepin
dihydro-beta-agarofuran
5956-09-2
deoxybaimuxinol
beta-agarofuran, dihydro-
CHEBI:71547
(3r,5as,9r,9as)-2,2,5a,9-tetramethyloctahydro-2h-3,9a-methano-1-benzoxepine
SCHEMBL2400604
Q27139701
(1s,2r,6s,9r)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.01,6]dodecane
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
organic heterotricyclic compoundAn organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.
bridged compoundA polycyclic compound in which two rings have two or more atoms in common.
eudesmane sesquiterpenoidAny sesquiterpenoid having a eudesmane skeleton.
cyclic etherAny ether in which the oxygen atom forms part of a ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (53)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (1.89)18.2507
2000's3 (5.66)29.6817
2010's36 (67.92)24.3611
2020's13 (24.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.75%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other56 (98.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]